Colonic butyrate- algesic or analgesic?

Neurogastroenterology and Motility

Volumn 23, Issue 11, 2011, Pages 975-979

  Kannampalli, P ^a   Shaker, R ^a   Sengupta, J N ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

colonic hypersensitivity; Inflammatory bowel syndrome; Short chain fatty acids; Sodium butyrate

Indexed keywords

BUTYRIC ACID;

ABDOMINAL PAIN; COLON; DIETARY FIBER; HIGH FIBER DIET; HUMAN; IRRITABLE COLON; NONHUMAN; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; VISCERAL PAIN;

ABDOMINAL PAIN; ANIMALS; BUTYRATES; CLINICAL TRIALS AS TOPIC; COLON; DIETARY FIBER; HUMANS; IRRITABLE BOWEL SYNDROME; RATS; VISCERAL PAIN;

EID: 80053908863     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2011.01775.x     Document Type: Note

References (44)

1. Brandt LJ, Bjorkman D, Fennerty MB et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97: S7-26.
2. Longstreth GF. Definition and classification of irritable bowel syndrome: current consensus and controversies. Gastroenterol Clin North Am 2005; 32: 173-87.
3. Arebi N, Gurmany S, Bullas D, Hobson A, Stagg A, Kamm M. The psychoneuroimmunology of irritable bowel syndrome-an exploration of interactions between psychological, neurological and immunological observations. Aliment Pharmacol Ther 2008; 28: 830-40.
4. Camilleri M, McKinzie S, Busciglio I et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008; 6: 772-81.
5. Barbara G, Cremon C, De Giorgio R et al. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep 2011; 13: 308-15.
6. Chang HY, Kelly EC, Lembo AJ. Current gut-directed therapies for irritable bowel syndrome. Curr Treat Options Gastroenterol 2006; 9: 314-23.
7. Roberfroid M, Gibson GR, Hoyles L et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010; 104: S1-63.
8. Cumming JH, Branch WJ. Fermentation and the production of short chain fatty acids in the human large intestine. In: Vahouny GB, Kritchevsky D, eds. Dietary Fiber: Basic and Clinical Aspect. New York: Plenum, 1986: 131-52.
9. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006; 40: 235-43.
10. Bingham SA, Day NE, Luben R et al. Dietary fiber in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 2003; 361: 1496-501.
11. Park Y, Hunter DJ, Spiegelman D et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 2005; 294: 2849-57.
12. Roda A, Simoni P, Magliulo M et al. A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon. World J Gastroenterol 2007; 13: 1079-84.
13. Wachtershauser A, Stein J. Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr 2000; 39: 164-71.
14. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. The role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104-19.
15. Boren J, Lee WN, Bassilian S et al. The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation. J Biol Chem 2003; 278: 28395-402.
16. Ogawa H, Rafiee P, Fisher PJ, Johnson NA, Otterson MF, Binion DG. Butyrate modulates gene and protein expression in human intestinal endothelial cells. Biochem Biophys Res Commun 2003; 309: 512-9.
17. Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut 2003; 52: 1442-7.
18. Gaudier E, Jarry A, Blottière HM et al. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am J Physiol Gastrointest Liver Physiol 2004; 287: G1168-74.
19. Blache D, Gesquiere L, Loreau N, Durand P. Oxidant stress: the role of nutrients in cell-lipoprotein interactions. Proc Nutr Soc 1999; 58: 559-63.
20. Rosignoli P, Fabiani R, De Bartolomeo A et al. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis 2001; 22: 1675-80.
21. Kvietys PR, Granger DN. Effect of volatile fatty acids on blood flow and oxygen uptake by the dog colon. Gastroenterology 1981; 80: 962-9.
22. Venkatraman A, Ramakrishna BS, Shaji RV, Kumar NS, Pulimood A, Patra S. Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-kappaB. Am J Physiol Gastrointest Liver Physiol 2003; 285: 177-84.
23. Bordin M, D-Atri F, Guillemot L, Citi S. Histone deacetylase inhibitors upregulate the expression of tight junction proteins. Mol Cancer Res 2004; 2: 692-701.
24. Scheppach W, Sommer H, Kirchner T et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992; 103: 51-6.
25. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 1989; 320: 23-8.
26. Bowling TE, Raimundo AH, Grimble GK, Silk DB. Reversal by shortchain fatty acids of colonic fluid secretion induced by enteral feeding. Lancet 1993; 342: 1266-8.
27. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980; 21: 793-8.
28. McIntyre A, Gibson PR, Young GP. Butyrate production from dietary fiber and protection against large bowel cancer in a rat model. Gut 1993; 34: 386-91.
29. Young GP, McIntyre A, Albert V, Folino M, Muir JG, Gibson PR. Wheat bran suppresses potato starch-potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat model. Gastroenterology 1996; 110: 508-14.
30. Scheppach W, Christl SU, Bartram HP, Richter F, Kasper H. Effects of short-chain fatty acids on the inflamed colonic mucosa. Scand J Gastroenterol 1997; 222: 53-7.
31. Kato K, Ishii Y, Mizuno S et al. Usefulness of rectally administering [1-(13)C]-butyrate for breath test in patients with active and quiescent ulcerative colitis. Scand J Gastroenterol 2007; 42: 207-14.
32. Hamer HM, Jonkers DM, Vanhoutvin SA et al. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin Nutr 2010; 29: 738-44.
33. Liu Q, Shimoyama T, Suzuki K, Umeda T, Nakaji S, Sugawara K. Effect of sodium butyrate on reactive oxygen species generation by human neutrophils. Scand J Gastroenterol 2001; 36: 744-50.
34. Cavaglieri CR, Nishiyama A, Fernandes LC, Curi R, Miles EA, Calder PC. Differential effects of short chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci 2003; 73: 1683-90.
35. Bourdu S, Dapoigny M, Chapuy E et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 2005; 128: 1996-2008.
36. Vera-Portocarrero LP, Ossipov MH, King T, Porreca F. Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan. Gastroenterology 2008; 135: 1369-78.
37. Lian B, Vera-Portocarrero L, King T, Ossipov MH, Porreca F. Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity. Brain Res 2010; 1358: 64-70.
38. Vanhoutvin SA, Troost FJ, Kilkens TO et al. The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroenterol Motil 2009; 21: 952-76.
39. Tarrerias AL, Millecamps M, Alloui A et al. Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS induced colonic inflammation in rats. Pain 2002; 100: 91-7.
40. Holzer P. The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol 2008; 155: 1145-62.
41. Matricon J, Gelot A, Etienne M, Lazdunski M, Muller E, Ardid D. Spinal cord plasticity and acid-sensing ion channels involvement in a rodent model of irritable bowel syndrome. Eur J Pain 2011; 15: 335-43.
42. Chen PS, Wang CC, Bortner CD et al. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 2007; 149: 203-12.
43. Lupton J. Microbial degradation products influence colon cancer risk: the butyrate controversy. J Nutr 2004; 134: 479-82.
44. Le Blay G, Blottiere HM, Ferrier L et al. Short-chain fatty acids induce cytoskeletal and extracellular protein modifications associated with modulation of proliferation in primary culture of rat intestinal smooth muscle cells. Dig Dis Sci 2000; 45: 1623-30.